Literature DB >> 26099726

Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses.

Ugo Borges Pinheiro1, Carlos Alberto de Carvalho Fraga1, Danilo Cangussu Mendes1, Lucyana Conceição Farias1, Cláudio Marcelo Cardoso2, Christine Mendes Silveira2, Marcos Flávio Silveira Vasconcelos D'Angelo3, Kimberly Marie Jones4, Sérgio Henrique Souza Santos5, Alfredo Maurício Batista de Paula1, André Luiz Sena Guimarães6.   

Abstract

It is estimated that 7.6 million people will die as a consequence of head and neck squamous cell carcinoma (HNSCC). Genetic predisposition has emerged as an important risk factor in the development and prognosis of HNSCC. Considering this, the aim of the current study is to assess whether codon 72 SNP of the TP53 gene (rs1042522) is associated with an increased odds ratio of developing HNSCC or with a worse prognosis in patients with HNSCC. Analysis of the rs1042522 in HNSCC patients and in control individuals. Differences between the case and control groups were determined using chi-squared tests. Multivariate analysis was performed to evaluate the odds ratio of HNSCC. Fussy C Means Clustering was to cluster HNSCC patients for survival analyses. Time of survival was calculated using the Kaplan-Meier estimator and comparing this to the log rank test. Statistical significance was set at p < 0.05. A total of 71.4 % of the Arg/Arg genotype were from HNSCC patients, while only 28.6 % of Arg/Arg genotype were found in the control group. Logistic regression demonstrated that the Arg/Arg genotype, smoking, and alcohol consumption increase the odds ratio of HNSCC. No association between TP53 codon 72 polymorphism and P53 expression. No association between rs1042522 and survival or prognoses was observed. This study identified that individuals carrying the arginine allele at rs1042522 have an increased odds ratio of HNSCC. However, no association between codon 72 SNP of the TP53 gene and HNSCC prognosis or P53 expression was observed.

Entities:  

Keywords:  Oral cancer; Survival; Tumor suppressor gene; p53

Mesh:

Substances:

Year:  2015        PMID: 26099726     DOI: 10.1007/s13277-015-3677-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

1.  SUMO-specific protease 2 in Mdm2-mediated regulation of p53.

Authors:  M Jiang; S-Y Chiu; W Hsu
Journal:  Cell Death Differ       Date:  2010-12-24       Impact factor: 15.828

2.  Genetic variants in DNA repair predicts the survival of patients with esophageal cancer.

Authors:  Jang-Ming Lee; Pei-Wen Yang; Shi-Yi Yang; Tzu-Hsuen Chuang; En-Chi Tung; Jin-Shing Chen; Pei-Ming Huang; Yung-Chie Lee
Journal:  Ann Surg       Date:  2011-05       Impact factor: 12.969

3.  P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians.

Authors:  Ting Xu; Zi-Cheng Xu; Qin Zou; Bin Yu; Xin-En Huang
Journal:  Asian Pac J Cancer Prev       Date:  2012

4.  TP53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of Brazilian women with cervical lesions.

Authors:  Ilce Ferreira da Silva; Rosalina Jorge Koifman; Claudia Quinto Santos Souza; Olimpio Ferreira de Almeida Neto; Sergio Koifman
Journal:  J Toxicol Environ Health A       Date:  2010

5.  No association between the Trp53 codon 72 polymorphism and head and neck cancer: a case-control study in a South Indian population.

Authors:  K Suresh; R Chandirasekar; B Lakshman Kumar; R Venkatesan; K Sasikala
Journal:  Asian Pac J Cancer Prev       Date:  2010

6.  Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.

Authors:  Yuxin Zheng; Hongbing Shen; Erich M Sturgis; Li-E Wang; Sanjay Shete; Margaret R Spitz; Qingyi Wei
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-07       Impact factor: 4.254

7.  Expression, polymorphism and methylation pattern of interleukin-6 in periodontal tissues.

Authors:  Florença Abdanur Stefani; Michelle Beatriz Viana; Ana Carolina Dupim; João Artur Ricieri Brito; Ricardo Santiago Gomez; José Eustáquio da Costa; Paula Rocha Moreira
Journal:  Immunobiology       Date:  2012-12-13       Impact factor: 3.144

8.  Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.

Authors:  Shogo Shinohara; Masahiro Kikuchi; Risa Tona; Yuji Kanazawa; Ippei Kishimoto; Hiroyuki Harada; Yukihiro Imai; Yu Usami
Journal:  Jpn J Clin Oncol       Date:  2014-01-26       Impact factor: 3.019

9.  The p53 codon 72 polymorphism and the risk of oral cancer in a Chinese Han population.

Authors:  Guangping Jing; Kewen Lv; Xiaohui Jiao
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-02

10.  Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer.

Authors:  Regine Schneider-Stock; Christian Mawrin; Christiane Motsch; Carsten Boltze; Brigitte Peters; Roland Hartig; Peter Buhtz; Anja Giers; Astrid Rohrbeck; Bernd Freigang; Albert Roessner
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

View more
  1 in total

1.  Photodynamic therapy mediated by nanoparticles Aluminum Chloro Phthalocyanine in oral squamous carcinoma cells.

Authors:  Lilian Mendes Borburema Cangussu; Ludmilla Regina de Souza; Marcela Gonçalves de Souza; Renato Sobral Monteiro Junior; Luis Alexandre Muehlmann; Paulo Narcizo de Souza; Lucyana Conceição Farias; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; André Luiz Sena Guimarães
Journal:  Lasers Med Sci       Date:  2022-02-04       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.